tiprankstipranks
Advertisement
Advertisement

ADCT Stock Latest News

ADC Therapeutics: Strengthening Fundamentals, ZYNLONTA Pipeline Momentum, and Increased $8 Target Support Buy Rating
RatingsADC Therapeutics: Strengthening Fundamentals, ZYNLONTA Pipeline Momentum, and Increased $8 Target Support Buy Rating
1d ago
ADCT
ADC Therapeutics price target raised to $8 from $7 at H.C. Wainwright
PremiumThe Fly
ADC Therapeutics price target raised to $8 from $7 at H.C. Wainwright
1d ago
ADCT
ADC Therapeutics files to sell 9.83M common shares for holders
PremiumThe Fly
ADC Therapeutics files to sell 9.83M common shares for holders
14d ago
ADCT
ADC Therapeutics reports Q4 adjusted EPS (9c), consensus (27c)
PremiumThe Fly
ADC Therapeutics reports Q4 adjusted EPS (9c), consensus (27c)
14d ago
ADCT
ADC Therapeutics sees cash runway at least into 2028
PremiumThe Fly
ADC Therapeutics sees cash runway at least into 2028
14d ago
ADCT
ADC Therapeutics Ltd (ADCT) Q4 Earnings Cheat Sheet
PremiumPre-EarningsADC Therapeutics Ltd (ADCT) Q4 Earnings Cheat Sheet
16d ago
ADCT
ADC Therapeutics Amends Royalty Deal, Issues New Warrants
Premium
Company Announcements
ADC Therapeutics Amends Royalty Deal, Issues New Warrants
29d ago
8K
ADCT
ADC Therapeutics announces amended HealthCare Royalty financing agreement
Premium
The Fly
ADC Therapeutics announces amended HealthCare Royalty financing agreement
29d ago
ADCT
ADC Therapeutics participates in a conference call with Cantor
PremiumThe Fly
ADC Therapeutics participates in a conference call with Cantor
2M ago
ADCT
ADC Therapeutics outlines ZYNLONTA-focused growth and financing strategy
PremiumCompany Announcements
ADC Therapeutics outlines ZYNLONTA-focused growth and financing strategy
2M ago
8K
ADCT
ADC Therapeutics Announces Preliminary 2025 Financial Results and Outlook
PremiumCompany Announcements
ADC Therapeutics Announces Preliminary 2025 Financial Results and Outlook
2M ago
8K
ADCT
ADC Therapeutics sees FY25 net product revenue $73M
PremiumThe Fly
ADC Therapeutics sees FY25 net product revenue $73M
2M ago
ADCT
ADC Therapeutics sees Q4 net product revenue $22M
PremiumThe FlyADC Therapeutics sees Q4 net product revenue $22M
2M ago
ADCT
ADC Therapeutics Reports Promising LOTIS-7 Trial Results
Premium
Company Announcements
ADC Therapeutics Reports Promising LOTIS-7 Trial Results
4M ago
8K
ADCT
Promising LOTIS-7 Trial Results Reinforce Buy Rating for ADC Therapeutics
Premium
Ratings
Promising LOTIS-7 Trial Results Reinforce Buy Rating for ADC Therapeutics
4M ago
ADCT
ADC Therapeutics updates data from Phase 1b trial of Zynlonta in lymphoma
PremiumThe Fly
ADC Therapeutics updates data from Phase 1b trial of Zynlonta in lymphoma
4M ago
ADCT
ADC Therapeutics: Strong Financials and Upcoming Trial Catalysts Support Buy Rating
PremiumRatings
ADC Therapeutics: Strong Financials and Upcoming Trial Catalysts Support Buy Rating
4M ago
ADCT
ADC Therapeutics Reports Q3 2025 Financial Results
PremiumCompany Announcements
ADC Therapeutics Reports Q3 2025 Financial Results
4M ago
ADCT
ADC Therapeutics Q3 2025 Earnings Call Highlights
PremiumCompany Announcements
ADC Therapeutics Q3 2025 Earnings Call Highlights
4M ago
ADCT
ADC Therapeutics files to sell 14.7M common shares for holders
PremiumThe FlyADC Therapeutics files to sell 14.7M common shares for holders
4M ago
ADCT
ADC Therapeutics reports Q3 adjsuted EPS (19c), consensus (36c)
Premium
The Fly
ADC Therapeutics reports Q3 adjsuted EPS (19c), consensus (36c)
4M ago
ADCT
Is ADCT a Buy, Before Earnings?
Premium
Pre-Earnings
Is ADCT a Buy, Before Earnings?
5M ago
ADCT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >